ATE398623T1 - Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer - Google Patents

Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer

Info

Publication number
ATE398623T1
ATE398623T1 AT00966144T AT00966144T ATE398623T1 AT E398623 T1 ATE398623 T1 AT E398623T1 AT 00966144 T AT00966144 T AT 00966144T AT 00966144 T AT00966144 T AT 00966144T AT E398623 T1 ATE398623 T1 AT E398623T1
Authority
AT
Austria
Prior art keywords
carbamat
hexahydrofuro
ylsulfonyl
benzodioxol
furan
Prior art date
Application number
AT00966144T
Other languages
English (en)
Inventor
Piet Wigerinck
Guangyang Wang
Michael Eissenstat
John Erickson
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of ATE398623T1 publication Critical patent/ATE398623T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00966144T 1999-10-06 2000-10-06 Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer ATE398623T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15785099P 1999-10-06 1999-10-06

Publications (1)

Publication Number Publication Date
ATE398623T1 true ATE398623T1 (de) 2008-07-15

Family

ID=22565540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00966144T ATE398623T1 (de) 1999-10-06 2000-10-06 Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer

Country Status (25)

Country Link
US (2) US6649651B1 (de)
EP (1) EP1222192B8 (de)
JP (1) JP4951179B2 (de)
KR (1) KR100792391B1 (de)
CN (1) CN1191256C (de)
AP (1) AP1459A (de)
AT (1) ATE398623T1 (de)
AU (1) AU781656B2 (de)
BR (1) BR0014602A (de)
CA (1) CA2386850C (de)
CZ (1) CZ300031B6 (de)
DE (1) DE60039244D1 (de)
DK (1) DK1222192T3 (de)
ES (1) ES2307533T3 (de)
HU (1) HU228938B1 (de)
IL (2) IL149005A0 (de)
MX (1) MXPA02003607A (de)
NO (1) NO327996B1 (de)
NZ (1) NZ518580A (de)
OA (1) OA12053A (de)
PL (1) PL204924B1 (de)
RU (1) RU2247123C2 (de)
SK (1) SK287153B6 (de)
WO (1) WO2001025240A1 (de)
ZA (1) ZA200202655B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL204924B1 (pl) * 1999-10-06 2010-02-26 Tibotec Pharm Ltd Heksahydrofuro [2,3-b] furanylo-3-N-{3(1,3-benzodioksolilo-5-sulfonylo) (izobutylo) amino] -1-benzylo-2-hydroksypropylo} karbaminian oraz jego zastosowanie
OA12464A (en) * 2001-04-09 2006-05-24 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.
AP1758A (en) * 2001-09-10 2007-07-30 Tibotec Pharm Ltd Method for the preparation of hexahydro-furo [2,3-b]furan-3-ol.
AU2003202914A1 (en) * 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
IL165043A0 (en) 2002-05-17 2005-12-18 Tibotec Pharm Ltd broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
OA12893A (en) * 2002-08-02 2006-10-13 Tibotec Pharm Ltd Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors.
EP1589018A4 (de) 2002-12-27 2007-03-14 Sumitomo Chemical Co Herstellungsverfahren für hexahydrofurofuranol-derivate, zwischenprodukt davon und herstellungsverfahren dafür
JP2007528423A (ja) * 2004-03-11 2007-10-11 セコイア、ファーマシューティカルズ、インコーポレイテッド 耐性防止レトロウイルスプロテアーゼ阻害薬
TWI383975B (zh) 2004-03-31 2013-02-01 悌柏泰克醫藥有限公司 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
KR100698291B1 (ko) * 2004-12-29 2007-03-22 엘지전자 주식회사 조명계
DK1856125T3 (da) 2005-02-25 2009-12-07 Tibotec Pharm Ltd Syntese af proteasehæmmerforstadie
FR2888849B1 (fr) * 2005-07-19 2007-10-05 Pierre Fabre Medicament Sa Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine
PL2049506T5 (pl) 2006-07-07 2024-09-09 Gilead Sciences, Inc. Modulatory farmakokinetycznych właściwości leków
WO2008013834A1 (en) * 2006-07-24 2008-01-31 Gilead Sciences, Inc., Bisfuranyl protease inhibitors
CN102432621B (zh) 2006-11-09 2016-02-17 爱尔兰詹森科学公司 六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
EP2120562A4 (de) * 2006-11-21 2010-01-13 Purdue Research Foundation Verfahren und zusammensetzungen zur behandlung von hiv-infektionen
MX2009008935A (es) 2007-02-23 2009-11-02 Gilead Sciences Inc Moduladores de las propiedades farmacocineticas de productos terapeuticos.
WO2008115894A1 (en) 2007-03-16 2008-09-25 Sequoia Pharmaceuticals Benzofuran-derived hiv protease inhibitors
ES2438275T3 (es) 2007-07-06 2014-01-16 Gilead Sciences, Inc. Moduladores de propiedades farmacocinéticas de agentes terapéuticos
US8759379B2 (en) 2008-01-04 2014-06-24 Gilead Sciences, Inc. Inhibitors of cytochrome P450
US20110046199A1 (en) * 2008-01-17 2011-02-24 Purdue Research Foundation Small molecule inhibitors of hiv proteases
EP2307345A4 (de) 2008-07-01 2012-05-02 Purdue Research Foundation Nichtpeptidinhibitoren der hiv-1-protease
WO2010006050A1 (en) 2008-07-09 2010-01-14 Purdue Research Foundation Hiv protease inhibitors and methods for using
AU2010338425B2 (en) 2009-12-21 2015-07-23 Janssen Sciences Ireland Uc Degradable removable implant for the sustained release of an active compound
US8841467B2 (en) 2010-11-23 2014-09-23 Mylan Laboratories Limited Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
JPWO2014024898A1 (ja) 2012-08-09 2016-07-25 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69311810T2 (de) * 1992-08-25 1997-11-27 Monsanto Co N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren
ES2123065T3 (es) * 1992-08-25 1999-01-01 Searle & Co Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
EP0715618B1 (de) * 1993-08-24 1998-12-16 G.D. Searle & Co. Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
CA2872424C (en) * 1998-06-23 2017-03-07 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Bisfuran derivatives useful in preventing the emergence of multidrug resistant hiv strains and treatment of hiv
AU4828199A (en) * 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
PL204924B1 (pl) * 1999-10-06 2010-02-26 Tibotec Pharm Ltd Heksahydrofuro [2,3-b] furanylo-3-N-{3(1,3-benzodioksolilo-5-sulfonylo) (izobutylo) amino] -1-benzylo-2-hydroksypropylo} karbaminian oraz jego zastosowanie

Also Published As

Publication number Publication date
CA2386850A1 (en) 2001-04-12
CN1407987A (zh) 2003-04-02
JP2003511383A (ja) 2003-03-25
US20050261364A1 (en) 2005-11-24
NO327996B1 (no) 2009-11-02
HK1054746A1 (en) 2003-12-12
HU228938B1 (hu) 2013-06-28
IL149005A (en) 2006-12-31
EP1222192B1 (de) 2008-06-18
KR100792391B1 (ko) 2008-01-08
CZ300031B6 (cs) 2009-01-14
US7157495B2 (en) 2007-01-02
HUP0203130A3 (en) 2005-01-28
HUP0203130A2 (hu) 2003-01-28
PL204924B1 (pl) 2010-02-26
OA12053A (en) 2006-05-02
SK5702002A3 (en) 2003-01-09
CN1191256C (zh) 2005-03-02
NO20021598D0 (no) 2002-04-04
WO2001025240A1 (en) 2001-04-12
SK287153B6 (sk) 2010-01-07
AU7663800A (en) 2001-05-10
ZA200202655B (en) 2003-09-23
RU2247123C2 (ru) 2005-02-27
DE60039244D1 (de) 2008-07-31
AP2002002472A0 (en) 2002-06-30
MXPA02003607A (es) 2003-07-28
NZ518580A (en) 2004-01-30
ES2307533T3 (es) 2008-12-01
IL149005A0 (en) 2002-11-10
CA2386850C (en) 2010-03-30
US6649651B1 (en) 2003-11-18
DK1222192T3 (da) 2008-10-20
NO20021598L (no) 2002-05-29
KR20020067503A (ko) 2002-08-22
PL354351A1 (en) 2004-01-12
EP1222192A1 (de) 2002-07-17
CZ20021419A3 (cs) 2002-10-16
AP1459A (en) 2005-08-22
EP1222192B8 (de) 2008-10-01
JP4951179B2 (ja) 2012-06-13
BR0014602A (pt) 2002-06-11
AU781656B2 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
ATE398623T1 (de) Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer
EE200200273A (et) Uudsed diabeedivastased agensid
EE200500020A (et) Kuluvate osade ssteem pinnaset””tlemismasina t””seadise jaoks
DE60036365D1 (de) Klappankersystem für einen schutzschalter
DE60036411D1 (de) Schlagwerkzeug
ID29961A (id) Alat penakar
DE60014258D1 (de) Taillenbandverstellvorrichtung
DE50010271D1 (de) Handwerkzeugmaschine
DE50204164D1 (de) Gleisbaumaschine
ID26595A (id) Alat pemilah
ATE265449T1 (de) 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridin wirksam als herbizide
PL349774A1 (en) Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors
DE60008492D1 (de) Griffanordnung für koffer
IT1310733B1 (it) Macchina operatrice.
DE60002404D1 (de) Verbessertes handwerkzeug
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
DE59912578D1 (de) Turbomaschinenschaufel
AU2003243248A8 (en) Nanolithography molecular beam machine
EP1195163A4 (de) Serinprotease-inhibitoren
FI4404U1 (fi) Liitosyhde
ITLU990008V0 (it) Spalla portante a pettine
FI4195U1 (fi) Siirto- ja kuljetusväline
ITMC990046A0 (it) Gioco a pronostici.
FI3926U1 (fi) Kaasupesuri
BR1100661A (pt) Compostos inibidores de protease retroviral

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties